Ibrutinib Plus Obinutuzumab and Venetoclax in Relapsed/Refractory Mantle Cells Lymphoma Patients, Results of the OASIS PhaseI Clinical Trial
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Ibrutinib Plus Obinutuzumab and Venetoclax in Relapsed/Refractory Mantle Cells Lymphoma Patients, Results of the OASIS PhaseI Clinical Trial |
| Type de publication | Journal Article |
| Year of Publication | 2018 |
| Auteurs | Le Gouill S, Morschhauser F, Bouabdallah K, Cartron G, Casasnovas R-O, Milpied N-J, Gastinne T, Davies AJohn, Herbaux C, Chiron D, Callanan M, Rule S |
| Journal | BLOOD |
| Volume | 132 |
| Date Published | NOV 29 |
| Type of Article | Meeting Abstract |
| ISSN | 0006-4971 |
| DOI | 10.1182/blood-2018-99-113777 |